Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE technology, which enables better delivery of drugs to the lungs. The company is dedicated to improving the lives of patients with respiratory diseases and advancing the field of inhaled therapies.